Europlasma S.A. reported earnings results for the full year ended December 31, 2022. For the full year, the company reported sales was EUR 14.52 million compared to EUR 9.8 million a year ago. Net loss was EUR 15.92 million compared to EUR 12.67 million a year ago.

Basic loss per share from continuing operations was EUR 30. Diluted loss per share from continuing operations was EUR 30.